Clinical Research Directory
Browse clinical research sites, groups, and studies.
Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Summary
This prospective study is designed to evaluate the feasibility, efficacy, and safety of risk-stratified hypofractionated radiotherapy after breast-conserving surgery in patients with early breast cancer.
Official title: A Prospective Study of Risk-Stratified Hypofractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
649
Start Date
2026-06-15
Completion Date
2032-12-31
Last Updated
2026-06-18
Healthy Volunteers
No
Interventions
Whole-breast irradiation and tumor bed boost
Whole-breast irradiation: 36 Gy in 15 fractions; Tumor bed boost: 48 Gy in 15 fractions
Partial-breast irradiation
Partial-breast irradiation: 40.05 Gy in 15 fractions or 26 Gy in 5 fractions
Locations (1)
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China